Literature DB >> 50500

Adenocarcinoma of the lung: clinicopathological study.

P Marabella, H Takita.   

Abstract

A review of our 247 patients with adenocarcinoma of the lung revealed the overall five year survival rate to be only 0.81%. Lung resection offers the chance of cure if the lesion is peripherally located and without lymph node involvement. Direct chest wall invasion by tumor is not contraindication to surgery. Radiation therapy was not especially effective in our series. Several chemotherapeutic agents gave an overall response of 31.1%.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 50500     DOI: 10.1002/jso.2930070306

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  3 in total

1.  Cyclic combination chemotherapy in advanced adenocarcinoma of the lung: comparison of two FAM schedules.

Authors:  W K Lam; S Y So; M Ip; D Y Yu
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 2.  Fluorodeoxyglucose-positron-emission tomography/computed tomography imaging for adrenal masses in patients with lung cancer: review and diagnostic algorithm.

Authors:  W Zachary Stone; David C Wymer; Benjamin K Canales
Journal:  J Endourol       Date:  2013-10-09       Impact factor: 2.942

3.  Long-term survival after surgical treatment of metachronous bilateral adrenal metastases of non-small cell lung carcinoma.

Authors:  Naohiro Taira; Tsutomu Kawabata; Takaharu Ichi; Kazuaki Kushi; Tomofumi Yohena; Hidenori Kawasaki; Kiyoshi Ishikawa
Journal:  Am J Case Rep       Date:  2014-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.